Preoperative staging of gastric cancer as precondition for multimodal treatment

• Published in: World journal of surgery Vol. 19; no. 4; p. 501
• Main Authors: Sendler, A, Dittler, H J, Feussner, H, Nekarda, H, Bollschweiler, E, Fink, U, Helmberger, H, Höfler, H, Siewert, J R
• Format: Journal Article
• Language: English
• Published: United States 01.07.1995
• Subjects: Combined Modality Therapy; Humans; Neoplasm Staging; Preoperative Care; Stomach Neoplasms - pathology; Stomach Neoplasms - therapy
• ISSN: 0364-2313; 1432-2323
• DOI: 10.1007/BF00294710

Preoperative staging of gastric cancer plays a crucial role every multimodal treatment protocol. At present, staging intends to be far more than evaluation of the depth of tumor infiltration into the organ wall, that is, T stage, nodular status (N category), and the presence of distant metastases (M stage) according to UICC criteria. In modern surgical oncology it includes more often the evaluation of prognostic factors such as the RAS-protein, p53 tumor suppressor gene, growth factor receptors, cell adhesion molecules, proteolytic factors, and proliferation-associated antigens. Furthermore, evaluation of nodular status is possible by sophisticated computer programs. The conventional staging of gastric cancer using endoscopy and sonography, conventional ultrasonography, computed tomography, and magnetic resonance imaging is discussed. Possible improvements of staging in oncologic centers should include surgical laparoscopy, laparoscopic ultrasonography, and meticulous evaluation of an abdominal lavage including immunohistochemical detection of free tumor cells. The most promising tumor biology-related prognostic factors in gastric cancer are briefly discussed.